Currently, high numbers of infections with the coronavirus SARS-CoV-2 are being recorded in many European countries. This leads to increased numbers of deaths and is a burden for society, health systems and the economy....
SARS-CoV-2 infections pose a global threat to human health and a formidable research challenge. One of the most urgent tasks is to gain a detailed understanding of the molecular interactions between the virus and the...
Prof Rolf Müller, Managing Director of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), has been awarded the Gottfried Wilhelm Leibniz Prize 2021 by the German Research Foundation (DFG) for his...
Hospital-acquired bacterial pneumonia is the most frequent nosocomial infection. It is mostly caused by the bacterium Staphylococcus aureus, which in many cases is already resistant to commonly used antibiotics and is...
Der Haushaltsausschuss des Bundes hat dem Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) Förderung in Höhe von 47 Millionen Euro für den weiteren Ausbau des Instituts zugesichert. Zusammen mit Mitteln...
The annual list of “Highly-cited researchers” identifies scientists who have demonstrated a significant impact in their chosen field over the last ten years through the publication of several highly-cited papers. This...
Infections with two pathogens pose a serious threat in the clinics. Researchers from Würzburg and Jena have developed a technique that provides new insights into this process and can be used as an early warning system....
Professor Jörg Vogel (Würzburg, Germany) has been announced as the President of the European Academy of Microbiology (EAM) from 1 January 2021. Prof Vogel will take over from Prof Philippe Sansonetti, the former...
